Anti-implantation effect of droloxifene in rats and its relationship with anti-estrogenic activity

Acta Pharmacologica Sinica

Volumn 26, Issue 10, 2005, Pages 1243-1247

  Huang, Yong ^a   Shen, Yu ^a   Feng, Ying ^a   Cao, Lin ^a   Leng, Ying ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

3 hydroxytamoxifen; Estrogen; Implantation; Progesterone; Rats

Indexed keywords

DROLOXIFENE; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG MECHANISM; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; FEMALE; IMPLANTATION; MALE; NIDATION; NONHUMAN; OPTIMAL DRUG DOSE; OVARY FUNCTION; PROGESTERONE BLOOD LEVEL; RADIOIMMUNOASSAY; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO IMPLANTATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; PREGNANCY; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN; TIME;

EID: 26044453901     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00191.x     Document Type: Article

References (14)

1. Eppenberger U, Wosikowski K, Kung W. Pharmacologic and biologic properties of droloxifene, a new antiestrogen. Am J Clin Oncol 1991; 14: S5-14.
2. Hasmann M, Rattel B, Loser R. Preclinical data for droloxifene. Cancer Lett 1994; 84: 101-6.
3. Ke HZ, Chen HK, Qi H, Pirie CM, Simmons HA, Ma YF, et al. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats. Bone 1995; 17: 491-6.
4. Grasser WA, Pan LC, Thompson DD, Paralkar VM. Common mechanism for the estrogen agonist and antagonist activities of droloxifene. J Cell Biochem 1997; 65: 159-71.
5. Palumbo A, Yeh J. Apoptosis as a basic mechanism in the ovarian cycle: follicular atresia and luteal regression. J Soc Gynecol Investig 1995; 2: 565-73.
6. Leng Y, Yang B, Cao L, Gu ZP. Effects of anordrin, droloxifene, nomegestrol, and mifepristone on cultured rat luteal cell apoptosis. Acta Pharmacol Sin 1999; 20: 400-4.
7. Leng Y, Gu ZP, Cao L. Apoptosis induced by droloxifene and c-myc, bax and bcl-2 mRNA expression in cultured luteal cells of rats. Eur J Pharmacol 2000; 409: 123-31.
8. Leng Y, Gu ZP, Cao L. Apoptosis induced by droloxifene and C-myc, Bax, Bcl-2 protein expression in corpus luteum of pregnant rats. Acta Pharmacol Sin 2001; 22: 327-34.
9. Leng Y, Feng Y, Cao L, Gu ZP. Effects of droloxifene on apoptosis and Bax, Bcl-2 protein expression of luteal cells in pseudopregnant rats. Acta Pharmacol Sin 2001; 22: 155-62.
10. Kodaman PH, Taylor HS. Hormonal regulation of implantation. Obstet Gynecol Clin North Am 2004; 31: 745-66.
11. Finn CA. Oestrogen and decidual cell reaction of implantation in mice. J Endocrinol 1965; 32: 223-9.
12. Liu Y, Jia XC. Changes of oestrogen and its receptor levels during implantation period in pregnant rats. Acta Physiol Sin 1981; 33: 44-50.
13. Watson J, Anderson FB, Alam M, O'Grady JE, Heald PJ. Plasma hormones and pituitary luteinizing hormone in the rat during the early stages of pregnancy and after post-coital treatment with tamoxifen (ICI 46,474). J Endocrinol 1975; 65: 7-17.
14. Bloxham PA, Pugh DM, Sharma SC. Abolition of the pre-implantation surge of plasma oestrogens in mice with tamoxifen. Irc Med Sci Reprod Obstet Gynecol 1977; 5: 432.